PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Holdup because communications with FDA have been in similar...

  1. 422 Posts.
    lightbulb Created with Sketch. 84
    Holdup because communications with FDA have been in similar style to PAR comms to shareholders. That leads to a lot of questions that PAR or its contractors have to answer. It also makes the FDA check and double check everything PAR says. All that takes time alas - and it would be very naive to put all the blame for the delays on the FDA.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.